​

Forte Biosciences Ownership | Who Owns Forte Biosciences?

OverviewForecastFinancialsChart

Forte Biosciences Ownership Summary

Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Tybourne capital management (hk) is the largest institutional shareholder, holding 6.90% of FBRX shares. Federated Hermes Kaufmann R is the top mutual fund, with 5.14% of its assets in Forte Biosciences shares.

FBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockForte Biosciences41.38%10.96%47.66%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tybourne capital management (hk)786.65K6.90%$10.17M
Geode capital management346.29K0.75%$186.01K
Blackrock174.86K0.38%$93.90K
Envestnet asset management18.86K0.17%$243.81K
Quest partners16.90K0.15%$218.48K
Two sigma investments, lp40.81K0.09%$21.92K
State street37.56K0.08%$20.17K
Susquehanna group, llp34.34K0.07%$18.44K
Ubs group24.31K0.05%$13.05K
Goldman sachs group20.78K0.05%$11.16K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tybourne capital management (hk)786.65K29.45%$10.17M
Quest partners16.90K0.02%$218.48K
Garde capital3.96K0.00%$51.20K
Private trust co na192.000.00%$2.48K
Envestnet asset management18.86K0.00%$243.81K
Two sigma securities---
Tower research capital llc (trc)---
Renaissance---
Advisor group---
Two sigma advisers, lp---

Top Buyers

HolderShares% AssetsChange
Tybourne capital management (hk)786.65K29.45%166.67K
Susquehanna group, llp34.34K-34.34K
Ubs group24.31K-24.28K
Envestnet asset management18.86K0.00%18.86K
Quest partners16.90K0.02%12.68K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---3.27M
Bvf inc/il---2.98M
Cable car capital---2.03M
Fred alger management---1.84M
Farallon capital management---1.81M

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp34.34K-34.34K$18.44K
Envestnet asset management18.86K0.00%18.86K$243.81K

Sold Out

HolderChange
Qube research-3.00
Fmr-128.00
Loring wolcott & coolidge fiduciary advisors llp/ma-193.00
Wells fargo & company/mn-253.00
Advisor group-1.08K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024333.13%19,068,3950.10%411.14%1042.86%620.00%
Mar 31, 202432-8.57%19,048,5370.98%602.43%7-30.00%5-
Dec 31, 2023359.38%18,863,22512.96%490.79%10-28.57%5-28.57%
Sep 30, 2023323.23%16,699,693381.91%7929.16%1427.27%7-12.50%
Jun 30, 2023313.33%3,465,339-10.35%164.87%1137.50%8-11.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann R628.21K5.14%628.21K
Federated Hermes Kaufmann Small Cap A426.49K3.49%426.49K
Vanguard Total Stock Mkt Idx Inv380.08K3.11%216.08K
Alger LIfe Sciences Innovation Composite205.37K1.68%-
Alger Small Cap Focus Composite176.87K1.45%176.87K
Alger Small Cap Focus I176.87K1.45%176.87K
Alger Small Cap Growth B157.75K1.29%-
Alger Health Sciences A134.57K1.10%-
Alger Small Cap Growth I-2102.90K0.84%-
Vanguard Institutional Extnd Mkt Idx Tr92.84K0.76%29.36K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 21, 2024Riley Antony A CHIEF FINANCIAL OFFICERBuy$125.00K
Dec 18, 2023Wagner Paul A. See RemarksBuy$7.53K
Dec 13, 2023Wagner Paul A. See RemarksBuy$7.35K
Dec 14, 2023Wagner Paul A. See RemarksBuy$7.20K
Dec 11, 2023Wagner Paul A. See RemarksBuy$16.19K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q3--

FBRX Ownership FAQ

Who Owns Forte Biosciences?

Forte Biosciences shareholders are primarily institutional investors at 41.38%, followed by 10.96% insiders and 47.66% retail investors. The average institutional ownership in Forte Biosciences's industry, Biotech Stocks , is 64.05%, which Forte Biosciences falls below.

Who owns the most shares of Forte Biosciences?

Forte Biosciences’s largest shareholders are Tybourne capital management (hk) (786.65K shares, 6.90%), Geode capital management (346.29K shares, 0.75%), and Blackrock (174.86K shares, 0.38%). Together, they hold 8.03% of Forte Biosciences’s total shares outstanding.

Does Blackrock own Forte Biosciences?

Yes, BlackRock owns 0.38% of Forte Biosciences, totaling 174.86K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 93.9K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Forte Biosciences’s biggest shareholder by percentage of total assets invested?

Tybourne capital management (hk) is Forte Biosciences’s biggest shareholder by percentage of total assets invested, with 29.45% of its assets in 786.65K Forte Biosciences shares, valued at 10.17M$.

Who is the top mutual fund holder of Forte Biosciences shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Forte Biosciences shares, with 5.14% of its total shares outstanding invested in 628.21K Forte Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools